Background: Refractory chronic inflammatory demyelinating polyneuropathy (CIDP) is a challenging subset of CIDP ... distribution and progression of signs and symptoms including weakness, sensory ...

faculty.chiba-u.jp Background Chronic inflammatory demyelinating polyneuropathy (CIDP) is currently classified into ‘typical’ CIDP and ‘atypical’ subtypes such as multifocal acquired demyelinating ...

Guillain-Barre Syndrome (GBS) is a rare neurological disorder in which the body’s immune system mistakenly attacks the ...

This systematic review demonstrated that IVIg and corticosteroids still provide the most effective first line treatment options for patients with active CIDP. The review also revealed there is a ...

Patient 1 had signs of sensory demyelinating polyneuropathy with decreased sensory conduction velocities, and Patient 5 had severe motor sensory demyelinating axonal polyneuropathy. QST revealed ...

The median levels of serum neurofilament light chain (sNfL) were greater in patients with CIDP who were treatment-naive compared to those who were on maintenance therapy. The levels of serum ...

GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been ...

Just over a month after it was approved in the UK, AstraZeneca and Ionis' Wainzua has been recommended for NHS use in the treatment of patients with polyneuropathy associated with transthyretin ...

The pattern of involvement was predominantly of an axonal sensory motor polyneuropathy. Neuropathy was found both in patients with alcohol-related and non-alcohol-related cirrhosis. The presence ...

Receive IFT’s Food News Now newsletter in your inbox.

Adult-onset genetic and metabolic diseases often present with clinical signs of spinal cord involvement, such as spasticity, weakness, sensory ataxia, impairment of vibration and position ... are more ...